JAMIE JADID: Open Payments
NPI 1245559061 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,067 in 101 payments from 27 companies in 2025. Trend: 2023 $2,833 · 2024 $3,006 · 2025 $4,067
Food & beverage: $2,872Travel & lodging: $1,194
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 10 | $1,521 |
| BETA BIONICS, INC. | 10 | $402 |
| Novo Nordisk Inc | 14 | $363 |
| Ascendis Pharma Endocrinology Inc | 5 | $202 |
| KYOWA KIRIN, INC. | 2 | $155 |
| Amgen Inc. | 9 | $153 |
| Dexcom, Inc. | 7 | $149 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $147 |
| Tandem Diabetes Care, Inc. | 1 | $101 |
| Xeris Pharmaceuticals, Inc. | 5 | $97 |
Products named: MINIMED 780G, iLet Bionic Pancreas, Yorvipath, Ozempic, Dexcom G6 Transmitter, Kerendia, Repatha, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across NV — which companies pay providers there.
